Paul Ruff to Predictive Value of Tests
This is a "connection" page, showing publications Paul Ruff has written about Predictive Value of Tests.
Connection Strength
0,021
-
Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J Clin Oncol. 2010 Nov 01; 28(31):4697-705.
Score: 0,021